Psychiatry AtlasMedication guide · United States

Antidepressant called a monoamine oxidase inhibitor (MAOI)

Phenelzine (Nardil)

Generic name
phenelzine sulfate
Brand names
Nardil
Medication class
MAOI antidepressant
Forms covered
Nardil oral tablets

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

FDA Boxed Warning

Nardil oral tablets.

Phenelzine carries a warning about increased suicidal thoughts or behaviors in children, adolescents and young adults taking antidepressants. Monitor patients of all ages for worsening depression, unusual behavior or suicidal thinking. It is not approved for pediatric patients.

Phenelzine, known as Nardil, is an MAO inhibitor used for selected depression after other treatments. Dietary restrictions, blood-pressure monitoring and medication washouts are essential.

What to expect: Full benefit can take four weeks or longer.

Warning signs
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Selected depression after inadequate response to more commonly used treatment — Adults. Older atypical-depression wording is retained in the source; not a pediatric indication.Nardil oral tablets.

What should I expect?

Full benefit can take four weeks or longer. Early dizziness or sleep changes do not tell you whether depression will improve.

Keep follow-up appointments to review mood, everyday functioning, blood pressure and the practical demands of food and medicine restrictions.

How do I take it safely?

Take the divided daily doses exactly as prescribed. Obtain a written food plan covering tyramine-rich aged, fermented or spoiled foods and the label’s other restrictions. Follow it throughout treatment and for two weeks after stopping. Avoid alcohol and unreviewed cough, cold, allergy, stimulant and weight-loss products.

The pharmacist must check every medicine and supplement. Many antidepressants, stimulants, decongestants, dextromethorphan and certain pain medicines are unsafe combinations. Switching requires product-specific waiting periods, often at least 14 days and at least five weeks after fluoxetine. Tell medical and dental teams about current or recent MAOI treatment.

Blood-pressure checks, including dizziness on standing, and assessment of liver and kidney health are important. Monitor mood, sleep and falls. Pregnancy and breastfeeding need discussion; pediatric safety is not established, and older adults are more prone to fainting.

Do not stop abruptly: severe withdrawal is possible. Take a forgotten dose when remembered unless the next is near, then skip it; never double. Food and medicine restrictions outlast the final tablet.

Do not use with pheochromocytoma, congestive heart failure, severe kidney impairment or kidney disease, a history of liver disease, or abnormal liver tests. These conditions need review before starting. Diabetes and bipolar symptoms also need monitoring.

Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.

What side effects should I know about?

  • Postural dizziness, sleep changes, dry mouth, constipation, weight gain and sexual effects.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Contact the prescriber promptly for new suicidal thoughts, worsening depression or unusual behavior. Use emergency care if there is immediate danger or the person cannot stay safe.
  • A sudden severe headache, stiff neck, pounding heartbeat, chest pain, sweating or confusion can signal dangerously high blood pressure. Stop the medicine and seek emergency assessment; do not treat it at home.
  • Agitation or confusion with fever, diarrhea, tremor or rigid muscles can be serotonin syndrome and needs urgent assessment. Seek emergency care for a seizure, collapse, serious breathing difficulty, facial or throat swelling, or suspected overdose. Overdose effects can be delayed even when someone initially feels well. Report jaundice, severe dizziness or new manic symptoms promptly.

What else should I know to stay safe?

  • Tyramine-rich aged, fermented or spoiled foods can cause a dangerous reaction. Follow the product-specific restrictions throughout treatment and for two weeks afterward. Avoid alcohol and unreviewed cough, cold, allergy, stimulant or weight-loss products.
  • Many antidepressants, stimulants, decongestants and certain pain medicines are unsafe combinations. Every prescription and supplement needs review; switching may require at least 14 days, or at least five weeks after fluoxetine. Tell medical and dental teams about recent MAOI use, and do not stop abruptly.
  • Do not use with pheochromocytoma, congestive heart failure, severe kidney impairment or kidney disease, a history of liver disease, abnormal liver tests, or product allergy. Monitor blood pressure, falls, mood, liver health and blood sugar when relevant. Pregnancy or breastfeeding needs discussion; pediatric safety is not established.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • The safety plan includes the kitchen and the medicine cabinet: a pharmacist can turn the product’s food restrictions into an everyday shopping plan.
  • Stopping tablets does not immediately end the interactions. Food restrictions continue for two weeks, and medicine changes need a separately checked waiting period.

How does it work?

Phenelzine slows the breakdown of several chemical messengers by inhibiting monoamine oxidase, an enzyme found throughout the body. This changes nerve-cell signaling and is thought to contribute to its antidepressant effect. Because the same enzyme also works outside the brain, this action helps explain important interactions with certain foods and medicines.

Explore medication science

How was this medicine developed?

The FDA approved Nardil in 1961. It remains an option for selected depression, usually after more commonly used medicines have not helped, because its food and drug interactions require substantial preparation.

How do I say the name?

Phenelzine: FEN-el-zeen. Capital letters show the stressed syllable.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Nardil prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology; Contraindications; Warnings, Warning to the Patient; Precautions, Drug Interactions..

  2. Phenelzine: FDA approval history
  3. Phenelzine: patient medicine information
  4. Nardil: Package Insert / Prescribing Information
  5. Phenelzine: FDA prescribing information
  6. Parnate: prescribing information
  7. Phenelzine: verified neutral parent, PubChem CID 3675
  8. What Is a Neurotransmitter? — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: How Neurotransmitters Work; Types of Neurotransmitters..

  9. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  10. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top